Comprehensive Modeling of Corneal Alkali Injury in the Rat Eye

References

• Fish R, Davidson RS. Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol 2010;21(4):317–321.
   PubMed Web of Science ®Google Scholar
• Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye (Lond) 2009;23(10):1966–1971.
   PubMed Web of Science ®Google Scholar
• Peate WF. Work-related eye injuries and illnesses. Am Fam Physician 2007 Apr 1;75(7):1017–1022.
   PubMed Web of Science ®Google Scholar
• Eslani M, Baradaran-Rafii A, Movahedan A, Djalilian AR. The ocular surface chemical burns. J Ophthalmol 2014;2014:196827.
   PubMed Web of Science ®Google Scholar
• Spector J, Fernandez WG. Chemical, thermal, and biological ocular exposures. Emerg Med Clin North Am 2008 Feb;26(1):125–36, vii.
   Google Scholar
• Sharma N, Singh D, Sobti A, Agarwal P, Velpandian T, Titiyal JS, et al. Course and outcome of accidental sodium hydroxide ocular injury. Am J Ophthalmol 2012 Oct;154(4):740–749.e2.
   Google Scholar
• Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 1997 Jan–Feb;41(4):275–313.
   PubMed Web of Science ®Google Scholar
• Miri A, Al-Deiri B, Dua HS. Long-term outcomes of autolimbal and allolimbal transplants. Ophthalmology 2010 Jun;117(6):1207–1213.
   PubMed Web of Science ®Google Scholar
• Oh JY, Choi H, Lee RH, Roddy GW, Ylostalo JH, Wawrousek E, et al. Identification of the HSPB4/TLR2/NF-kappaB axis in macrophage as a therapeutic target for sterile inflammation of the cornea. EMBO Mol Med 2012 May;4(5):435–448.
   PubMed Web of Science ®Google Scholar
• Zieske JD. Extracellular matrix and wound healing. Curr Opin Ophthalmol 2001 Aug;12(4):237–241.
   PubMed Web of Science ®Google Scholar
• Qazi Y, Wong G, Monson B, Stringham J, Ambati BK. Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull 2010 Feb 15; 81 (2–3): 198–210.
   PubMed Web of Science ®Google Scholar
• Kilic Muftuoglu I, Aydin Akova Y, Cetinkaya A. Clinical spectrum and treatment approaches in corneal burns. Turk J Ophthalmol 2015 Oct;45(5):182–187.
   PubMedGoogle Scholar
• Gupta N, Kalaivani M, Tandon R. Comparison of prognostic value of roper hall and dua classification systems in acute ocular burns. Br J Ophthalmol 2011 Feb;95(2):194–198.
   PubMed Web of Science ®Google Scholar
• Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997 May 15;89(10):3503–3521.
   PubMed Web of Science ®Google Scholar
• Fine A, Goldstein RH. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J Biol Chem 1987 Mar 15;262(8):3897–3902.
   PubMed Web of Science ®Google Scholar
• Pfister RR, Haddox JL, Yuille-Barr D. The combined effect of citrate/ascorbate treatment in alkali-injured rabbit eyes. Cornea 1991 Mar;10(2):100–104.
   PubMed Web of Science ®Google Scholar
• Saika S, Uenoyama K, Hiroi K, Tanioka H, Takase K, Hikita M. Ascorbic acid phosphate ester and wound healing in rabbit corneal alkali burns: epithelial basement membrane and stroma. Graefes Arch Clin Exp Ophthalmol 1993 Apr;231(4):221–227.
   PubMed Web of Science ®Google Scholar
• Pfister RR, Haddox JL, Snyder TL. Topical citrate inhibits the adherence of neutrophils to postcapillary venules. Cornea 1990 Jul;9(3):238–245.
   PubMed Web of Science ®Google Scholar
• Haddox JL, Pfister RR, Yuille-Barr D. The efficacy of topical citrate after alkali injury is dependent on the period of time it is administered. Invest Ophthalmol Vis Sci 1989 Jun;30(6):1062–1068.
   PubMed Web of Science ®Google Scholar
• Paterson CA, Williams RN, Parker AV. Characteristics of polymorphonuclear leukocyte infiltration into the alkali burned eye and the influence of sodium citrate. Exp Eye Res 1984 Dec;39(6):701–708.
   PubMed Web of Science ®Google Scholar
• Reim M, Beil KH, Kammerer G, Krehwinkel S. Influence of systemic ascorbic acid treatment on metabolite levels after regeneration of the corneal epithelium following mild alkali burns. Graefes Arch Clin Exp Ophthalmol 1982;218(2):99–102.
   PubMed Web of Science ®Google Scholar
• Pfister RR, Nicolaro ML, Paterson CA. Sodium citrate reduces the incidence of corneal ulcerations and perforations in extreme alkali-burned eyes–acetylcysteine and ascorbate have no favorable effect. Invest Ophthalmol Vis Sci 1981 Sep;21(3):486–490.
   PubMed Web of Science ®Google Scholar
• Brodovsky SC, McCarty CA, Snibson G, Loughnan M, Sullivan L, Daniell M, et al. Management of alkali burns: an 11-year retrospective review. Ophthalmology 2000 Oct;107(10):1829–1835.
   PubMed Web of Science ®Google Scholar
• Mackway-Jones K, Marsden J. Ascorbate for alkali burns to the eye. Emerg Med J 2003 Sep;20(5):465–466.
   PubMed Web of Science ®Google Scholar
• Hamill CE, Bozorg S, Peggy Chang HY, Lee H, Sayegh RR, Shukla AN, et al. Corneal alkali burns: a review of the literature and proposed protocol for evaluation and treatment. Int Ophthalmol Clin 2013 Fall;53(4):185–194.
   Google Scholar
• Cade F, Paschalis EI, Regatieri CV, Vavvas DG, Dana R, Dohlman CH. Alkali burn to the eye: protection using TNF-alpha inhibition. Cornea 2014 Apr;33(4):382–389.
   PubMed Web of Science ®Google Scholar
• Ferrari G, Bignami F, Giacomini C, Franchini S, Rama P. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. Invest Ophthalmol Vis Sci 2013 Mar 1;54(3):1680–1688.
   PubMed Web of Science ®Google Scholar
• Lu P, Li L, Liu G, Baba T, Ishida Y, Nosaka M, et al. Critical role of TNF-alpha-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization. Invest Ophthalmol Vis Sci 2012 Jun 14;53(7):3516–3526.
   PubMed Web of Science ®Google Scholar
• Sari ES, Yazici A, Aksit H, Yay A, Sahin G, Yildiz O, et al. Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats. Curr Eye Res 2015 Jan;40(1):48–55.
   PubMed Web of Science ®Google Scholar
• Sakimoto T. Potential Application of Biological Products for the Treatment of Ocular Surface Inflammation. Cornea 2015 Nov;34 Suppl 11:S153–S157.
   PubMed Web of Science ®Google Scholar
• Saika S, Miyamoto T, Yamanaka O, Kato T, Ohnishi Y, Flanders KC, et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-kappaB, in treatment of corneal alkali burns in mice. Am J Pathol 2005 May;166(5):1393–1403.
   PubMed Web of Science ®Google Scholar
• Bignami F, Giacomini C, Lorusso A, Aramini A, Rama P, Ferrari G. NK1 receptor antagonists as a new treatment for corneal neovascularization. Invest Ophthalmol Vis Sci 2014 Sep 16;55(10):6783–6794.
   PubMed Web of Science ®Google Scholar
• Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res 2003 Feb;76(2):161–167.
   PubMed Web of Science ®Google Scholar
• Kim DW, Lee SH, Shin MJ, Kim K, Ku SK, Youn JK, et al. PEP-1-FK506BP inhibits alkali burn-induced corneal inflammation on the rat model of corneal alkali injury. BMB Rep 2015 Nov;48(11):618–623.
   PubMed Web of Science ®Google Scholar
• Hoffart L, Matonti F, Conrath J, Daniel L, Ridings B, Masson GS, et al. Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone. Clin Experiment Ophthalmol 2010 May;38(4):346–352.
   PubMed Web of Science ®Google Scholar
• Liarakos VS, Papaconstantinou D, Vergados I, Douvali M, Theodossiadis PG. The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model. Eur J Ophthalmol 2014 May-Jun;24(3):299–308.
   PubMed Web of Science ®Google Scholar
• Chen WL, Lin CT, Lin NT, Tu IH, Li JW, Chow LP, et al. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. Invest Ophthalmol Vis Sci 2009 Apr;50(4):1659–1665.
   PubMed Web of Science ®Google Scholar
• Su W, Li Z, Li Y, Lin M, Yao L, Liu Y, et al. Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects. Invest Ophthalmol Vis Sci 2011 Nov 25;52(12):9108–9115.
   PubMed Web of Science ®Google Scholar
• Lee SH, Leem HS, Jeong SM, Lee K. Bevacizumab accelerates corneal wound healing by inhibiting TGF-beta2 expression in alkali-burned mouse cornea. BMB Rep 2009 Dec 31;42(12):800–805.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Lee JY, Lee SH, Choi TH. Accelerating repaired basement membrane after bevacizumab treatment on alkali-burned mouse cornea. BMB Rep 2013 Apr;46(4):195–200.
   PubMed Web of Science ®Google Scholar
• Almaliotis D, Koliakos G, Papakonstantinou E, Komnenou A, Thomas A, Petrakis S, et al. Mesenchymal stem cells improve healing of the cornea after alkali injury. Graefes Arch Clin Exp Ophthalmol 2015 Jul;253(7):1121–1135.
   PubMed Web of Science ®Google Scholar
• Holan V, Trosan P, Cejka C, Javorkova E, Zajicova A, Hermankova B, et al. A comparative study of the therapeutic potential of mesenchymal stem cells and limbal epithelial stem cells for ocular surface reconstruction. Stem Cells Transl Med 2015 Sep;4(9):1052–1063.
   PubMed Web of Science ®Google Scholar
• Yao L, Li ZR, Su WR, Li YP, Lin ML, Zhang WX, et al. Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn. PLoS One 2012;7(2):e30842.
   PubMed Web of Science ®Google Scholar
• Ke Y, Wu Y, Cui X, Liu X, Yu M, Yang C, et al. Polysaccharide hydrogel combined with mesenchymal stem cells promotes the healing of corneal alkali burn in rats. PLoS One 2015 Mar 19;10(3):e0119725.
   PubMed Web of Science ®Google Scholar
• Acar U, Pinarli FA, Acar DE, Beyazyildiz E, Sobaci G, Ozgermen BB, et al. Effect of allogeneic limbal mesenchymal stem cell therapy in corneal healing: role of administration route. Ophthalmic Res 2015;53(2):82–89.
   PubMed Web of Science ®Google Scholar
• Bu P, Vin AP, Sethupathi P, Ambrecht LA, Zhai Y, Nikolic N, et al. Effects of activated omental cells on rat limbal corneal alkali injury. Exp Eye Res 2014 Apr;121:143–146.
   PubMed Web of Science ®Google Scholar
• Choi JA, Choi JS, Joo CK. Effects of amniotic membrane suspension in the rat alkali burn model. Mol Vis 2011 Feb 5;17:404–412.
   Google Scholar
• Jiang A, Li C, Gao Y, Zhang M, Hu J, Kuang W, et al. In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization. Cornea 2006 Dec;25(10 Suppl 1):S36–S40.
   PubMed Web of Science ®Google Scholar
• Herretes S, Suwan-Apichon O, Pirouzmanesh A, Reyes JM, Broman AT, Cano M, et al. Use of topical human amniotic fluid in the treatment of acute ocular alkali injuries in mice. Am J Ophthalmol 2006 Aug;142(2):271–278.
   PubMed Web of Science ®Google Scholar
• Mills CD. M1 and M2 Macrophages: oracles of health and disease. Crit Rev Immunol 2012;32(6):463–488.
   PubMed Web of Science ®Google Scholar
• Shakiba Y, Mansouri K, Arshadi D, Rezaei N. Corneal neovascularization: molecular events and therapeutic options. Recent Pat Inflamm Allergy Drug Discov 2009 Nov;3(3):221–231.
   PubMedGoogle Scholar
• Uchiyama M, Shimizu A, Masuda Y, Nagasaka S, Fukuda Y, Takahashi H. An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model. Mol Vis 2013 Nov 1;19:2135–2150.
   Google Scholar
• Han Y, Shao Y, Lin Z, Qu YL, Wang H, Zhou Y, et al. Netrin-1 simultaneously suppresses corneal inflammation and neovascularization. Invest Ophthalmol Vis Sci 2012 Mar 9;53(3):1285–1295.
   PubMed Web of Science ®Google Scholar
• Den S, Sotozono C, Kinoshita S, Ikeda T. Efficacy of early systemic betamethasone or cyclosporin A after corneal alkali injury via inflammatory cytokine reduction. Acta Ophthalmol Scand 2004 Apr;82(2):195–199.
   PubMedGoogle Scholar
• Jiang TS, Cai L, Ji WY, Hui YN, Wang YS, Hu D, et al. Reconstruction of the corneal epithelium with induced marrow mesenchymal stem cells in rats. Mol Vis 2010 Jul 14;16:1304–1316.
   Google Scholar
• Figueroa-Ortiz LC, Martin Rodriguez O, Garcia-Ben A, Garcia-Campos J. Neovascular growth in an experimental alkali corneal burn model. Arch Soc Esp Oftalmol 2014 Aug;89(8):303–307.
   PubMedGoogle Scholar
• Liu X, Lin Z, Zhou T, Zong R, He H, Liu Z, et al. Anti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury. PLoS One 2011 Jan 31;6(1):e16712.
   PubMed Web of Science ®Google Scholar
• Maurice DM. The structure and transparency of the cornea. J Physiol 1957 Apr 30;136(2):263–286.
   PubMed Web of Science ®Google Scholar
• Goldman JN, Benedek GB, Dohlman CH, Kravitt B. Structural alterations affecting transparency in swollen human corneas. Invest Ophthalmol 1968 Oct;7(5):501–519.
   PubMedGoogle Scholar
• Goldman JN, Benedek GB. The relationship between morphology and transparency in the nonswelling corneal stroma of the shark. Invest Ophthalmol 1967 Dec;6(6):574–600.
   PubMedGoogle Scholar
• Saika S, Ooshima A, Shima K, Tanaka S, Ohnishi Y. Collagen types in healing alkali-burned corneal stroma in rabbits. Jpn J Ophthalmol 1996;40(3):303–309.
   PubMed Web of Science ®Google Scholar